Status:

WITHDRAWN

Cartilage Repair Using a Hyaluronic Acid-Based Scaffold With Bone Marrow Aspirate Compared With Microfracture for Focal Articular Cartilage Damage of the Hip

Lead Sponsor:

McMaster University

Conditions:

Femoroacetabular Impingement

Cartilage Damage

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

Femoroacetabular impingement (FAI) is a hip disorder resulting from a mismatch of the hip joint, resulting in hip pain and can potentially cause osteoarthritis. As the head of the femur (ball of the h...

Eligibility Criteria

Inclusion

  • Male and female patients aged 18-40 years
  • Hip pain lasting 6 months or more with no relief from documented non-operative modalities
  • Cam, Pincer, or Mixed FAI
  • Focal articular cartilage defects of the acetabulum on MRI, confirmed to be full thickness (International Cartilage Regeneration and Joint Preservation Society (ICRS) grade 3 or 4) during arthroscopic examination
  • Focal acetabular articular cartilage lesions measuring between 1x1 cm2 and 5x5 cm2 on MRI and confirmed on arthroscopic examination
  • Patient agrees to participate in the study-specific postoperative rehabilitation protocol
  • Patient can speak, read, and understand the language of the site
  • Patient has provided informed consent

Exclusion

  • Cartilage defects of the femoral head
  • Previous surgery on the study hip
  • Traumatic chondral injury of the hip from a single event
  • Presence of advanced osteoarthritis (Tonnis grade 2 or 3)
  • Known hypersensitivity or allergy to hyaluronate
  • Evidence of hip dysplasia (i.e. lateral centre edge angle \< 20˚)
  • Evidence of acetabular over coverage such as coxa profunda or coxa protrusion
  • Immunosuppressive or anti-proliferative medication use
  • Chronic pain syndromes
  • Significant medical co-morbidities (requiring assistance for activities of daily living (ADLs))
  • History of paediatric hip disease
  • Uncontrolled diabetes
  • Contraindications to MRI imaging (e.g. claustrophobia)
  • Patient is involved in ongoing legal or workplace claims
  • Patient is incarcerated
  • Patient who will likely have problems, in the judgement of the investigator, with maintaining follow-up

Key Trial Info

Start Date :

January 3 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 19 2024

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04875767

Start Date

January 3 2023

End Date

November 19 2024

Last Update

November 21 2024

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.